AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇹🇳

RITUXIMAB in Tunisia

7 products registered with DPM — 0 active, 7 expired

Brand / ProductReg. No.HolderStatusExpires
TRUXIMA
Solution à diluer pour perfusion / 500 mg
6653751HHIKMA Pharmaceuticalsexpired13 Jun 2022
TRUXIMA
Solution à diluer pour perfusion / 100 mg
6653752HHIKMA Pharmaceuticalsexpired13 Jun 2022
REDDITUX
Solution injectable pour perfusion / 100 mg/10 ml
20063011HDr Reddy's Laboratories Ltd Biologicsexpired5 Apr 2022
REDDITUX
Solution injectable pour perfusion / 500 mg/50ml
20063012HDr Reddy's Laboratories Ltd Biologicsexpired5 Apr 2022
MABTHERA
Solution injectable / 1400 mg/11.7ml
6993143HRoche Pharma (Schweiz) AGexpired10 Jun 2019
MABTHERA
Solution injectable / 500 mg/50ml
6993142HRoche Pharma (Schweiz) AGexpired5 May 2003
MABTHERA
Solution injectable / 100 mg/10ml
6993141HRoche Pharma (Schweiz) AGexpired2 May 2003

RITUXIMAB — DPM Registration Details

DPM (Tunisia) has 7 registered products containing RITUXIMAB, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.

Track RITUXIMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.